CMR Surgical
- Industry
- Medical Devices
- Founded Year
- 2014
- Headquarters
- Cambridge, United Kingdom
- Employee Count
- 815
Key People
- Massimiliano Colella - Chief Executive Officer
- Luke Hares - Chief Technology Officer and Co-Founder
- Per Vegard Nerseth - Chief Executive Officer
- Jon Pebody - Head of Outsourced Product Manufacture
- Robert Tansley - Board Member
Assessment
- Team
-
Aspect: Multiple successful MedTech entrepreneurs
Summary: The leadership team comprises experienced professionals with backgrounds in medical technology and business management.
The presence of multiple successful MedTech entrepreneurs in the leadership team enhances the company's strategic direction and operational execution.
- Clinical Need
-
Aspect: Very Strong
Summary: The Versius system addresses a significant need for minimally invasive surgical solutions.
With the increasing adoption of minimally invasive procedures, Versius offers a compelling solution that aligns with current clinical trends.
- Competition
-
Aspect: Very crowded + Strategics
Summary: The surgical robotics market is highly competitive, with established players like Intuitive Surgical.
Competing against well-established companies with extensive market presence requires strategic positioning and innovation.
- Technical Challenge
-
Aspect: Complex
Summary: Developing and refining surgical robotic systems involves significant technical complexities.
Ensuring precision, reliability, and safety in surgical robotics necessitates overcoming substantial engineering challenges.
- Patent
-
Aspect: Strong
Summary: The company holds a robust portfolio of patents protecting its technology.
Strong intellectual property rights safeguard the company's innovations and can deter potential competitors.
- Financing
-
Aspect: Well-funded
Summary: CMR Surgical has secured substantial funding from reputable investors.
Significant investments enable the company to scale operations and invest in research and development.
- Regulatory
-
Aspect: 510k/PMA
Summary: The Versius system has obtained regulatory approvals in multiple regions.
Achieving necessary approvals demonstrates compliance with safety and efficacy standards, essential for commercial success.
Opportunity Rollup
- Odds of Success
- 3.1
- Peak Market Share
- 3.7
- Segment CAGR
- 15%
- Market Segment
- Surgical Robotics
- Market Sub Segment
- Soft Tissue Surgery
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.19 |
| 2 | 0.56 |
| 3 | 1.30 |
| 4 | 2.59 |
| 5 | 3.70 |
Key Takeaway
CMR Surgical's Versius system addresses a significant clinical need in minimally invasive surgery, supported by strong leadership and substantial funding. However, the company faces challenges in a highly competitive market with technical complexities and regulatory hurdles.